Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,098) with videos related to
Page
of 110
Sort By:
Blood
|
August 15, 2013
BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells
Stephanie Beurlet, Nader Omidvar, Petra Gorombei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2020
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments
Rainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
Blood
|
January 14, 2014
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy
Jennifer A Woyach, Kelly Smucker, Lisa L Smith, et al.
Vaccines
|
August 29, 2024
COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region
Manuela Runge, Zahra Karimian, Mehrnaz Kheirandish, et al.
JAMA Oncology
|
July 17, 2015
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
Kami J Maddocks, Amy S Ruppert, Gerard Lozanski, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 18, 2014
Can neonatal sepsis be predicted in late preterm premature rupture of membranes? Development of a prediction model
David P van der Ham, Sander van Kuijk, Brent C Opmeer, et al.
Multiple Sclerosis and Related Disorders
|
December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings
Nick Rijke, Bassem I Yamout, Deanna Saylor, et al.
Cancer Discovery
|
August 11, 2018
The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation
Sean D Reiff, Rose Mantel, Lisa L Smith, et al.
Human Mutation
|
April 16, 2009
Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase
Sylvie Tuffery-Giraud, Christophe Béroud, France Leturcq, et al.
Arthritis Research & Therapy
|
February 18, 2016
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases
Tamarah D de Jong, Saskia Vosslamber, Elise Mantel, et al.
Page
of 110
Search research articles
Search
Showing results (1071-1080 of 1,098) with videos related to
Sort By:
Page
of 110
Blood
|
August 15, 2013
BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells
Stephanie Beurlet, Nader Omidvar, Petra Gorombei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2020
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments
Rainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
Blood
|
January 14, 2014
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy
Jennifer A Woyach, Kelly Smucker, Lisa L Smith, et al.
Vaccines
|
August 29, 2024
COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region
Manuela Runge, Zahra Karimian, Mehrnaz Kheirandish, et al.
JAMA Oncology
|
July 17, 2015
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
Kami J Maddocks, Amy S Ruppert, Gerard Lozanski, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 18, 2014
Can neonatal sepsis be predicted in late preterm premature rupture of membranes? Development of a prediction model
David P van der Ham, Sander van Kuijk, Brent C Opmeer, et al.
Multiple Sclerosis and Related Disorders
|
December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings
Nick Rijke, Bassem I Yamout, Deanna Saylor, et al.
Cancer Discovery
|
August 11, 2018
The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation
Sean D Reiff, Rose Mantel, Lisa L Smith, et al.
Human Mutation
|
April 16, 2009
Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase
Sylvie Tuffery-Giraud, Christophe Béroud, France Leturcq, et al.
Arthritis Research & Therapy
|
February 18, 2016
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases
Tamarah D de Jong, Saskia Vosslamber, Elise Mantel, et al.
Page
of 110